RBLX vs. CRSP

Last updated Jun 6, 2026

RBLX (Roblox Corporation) and CRSP (CRISPR Therapeutics AG) are both stocks. RBLX operates in Electronic Gaming & Multimedia (Communication Services), while CRSP operates in Biotechnology (Healthcare). Over the past 5 years, RBLX returned -15.93%/yr vs -14.47%/yr for CRSP. At a 0.37 correlation, their price movements are largely independent.

Performance

RBLX vs. CRSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Roblox Corporation (RBLX) and CRISPR Therapeutics AG (CRSP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RBLX achieves a -48.39% return, which is significantly lower than CRSP's -1.14% return.

RBLX

• 1D: -3.53%
• 1M: -4.43%
• YTD: -48.39%
• 6M: -56.56%
• 1Y: -55.61%
• 3Y*: 0.39%
• 5Y*: -15.93%
• 10Y*: —

CRSP

• 1D: -8.97%
• 1M: -5.88%
• YTD: -1.14%
• 6M: -8.86%
• 1Y: 34.40%
• 3Y*: -7.06%
• 5Y*: -14.47%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

RBLX vs. CRSP - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
RBLX Roblox Corporation	-48.39%	40.04%	26.55%	60.65%	-72.41%	48.43%
CRSP CRISPR Therapeutics AG	-1.14%	33.23%	-37.12%	54.00%	-46.36%	-38.96%

Correlation

The correlation between RBLX and CRSP is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.25
Correlation (3Y) Calculated over the trailing 3-year period	0.29
Correlation (5Y) Calculated over the trailing 5-year period	0.36
Correlation (All Time) Calculated using the full available price history since Mar 11, 2021	0.37

The correlation between RBLX and CRSP shifts across timeframes, from 0.25 (1 year) to 0.37 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap RBLX : $29.76B CRSP : $4.98B
EPS RBLX : -$1.57 CRSP : -$6.24
PS Ratio RBLX : 5.52 CRSP : 1.15K
PB Ratio RBLX : 68.90 CRSP : 2.74
Total Revenue (TTM) RBLX : $5.30B CRSP : $4.10M
Gross Profit (TTM) RBLX : $4.16B CRSP : -$171.17M
EBITDA (TTM) RBLX : -$944.43M CRSP : -$509.21M

Return for Risk

RBLX vs. CRSP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RBLX

RBLX Risk / Return Rank: 8
RBLX Sharpe Ratio Rank: 6
RBLX Sortino Ratio Rank: 7
RBLX Omega Ratio Rank: 7
RBLX Calmar Ratio Rank: 12
RBLX Martin Ratio Rank: 9

CRSP

CRSP Risk / Return Rank: 58
CRSP Sharpe Ratio Rank: 60
CRSP Sortino Ratio Rank: 59
CRSP Omega Ratio Rank: 56
CRSP Calmar Ratio Rank: 60
CRSP Martin Ratio Rank: 56

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RBLX vs. CRSP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Roblox Corporation (RBLX) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RBLX	CRSP	Difference
Sharpe ratio: Return per unit of total volatility	-0.94	0.55	-1.49
Sortino ratio: Return per unit of downside risk	-1.38	1.22	-2.60
Omega ratio: Gain probability vs. loss probability	0.83	1.14	-0.32
Calmar ratio: Return relative to maximum drawdown	-0.79	0.82	-1.61
Martin ratio: Return relative to average drawdown	-1.37	1.38	-2.75
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RBLX vs. CRSP - Sharpe Ratio Comparison

The current RBLX Sharpe Ratio is -0.94, which is lower than the CRSP Sharpe Ratio of 0.55. The chart below compares the historical Sharpe Ratios of RBLX and CRSP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	RBLX	CRSP	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.94	0.55	-1.49
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.23	-0.24	+0.01
Sharpe Ratio (All Time) Calculated using the full available price history	-0.13	0.23	-0.36

Drawdowns

RBLX vs. CRSP - Drawdown Comparison

The maximum RBLX drawdown since its inception was -82.79%, roughly equal to the maximum CRSP drawdown of -85.11%. Use the drawdown chart below to compare losses from any high point for RBLX and CRSP.

Drawdown Indicators

	RBLX	CRSP	Difference
Max Drawdown Largest peak-to-trough decline	-82.79%	-85.11%	+2.32%
Max Drawdown (1Y) Largest decline over 1 year	-70.82%	-42.25%	-28.57%
Max Drawdown (3Y) Largest decline over 3 years	-70.82%	-64.91%	-5.91%
Max Drawdown (5Y) Largest decline over 5 years	-82.79%	-80.68%	-2.11%
Current Drawdown Current decline from peak	-70.46%	-75.32%	+4.86%
Average Drawdown Average peak-to-trough decline	-52.98%	-49.19%	-3.79%
Ulcer Index Depth and duration of drawdowns from previous peaks	40.59%	25.06%	+15.53%

Volatility

RBLX vs. CRSP - Volatility Comparison

The current volatility for Roblox Corporation (RBLX) is 17.33%, while CRISPR Therapeutics AG (CRSP) has a volatility of 19.12%. This indicates that RBLX experiences smaller price fluctuations and is considered to be less risky than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RBLX	CRSP	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.33%	19.12%	-1.79%
Volatility (6M) Calculated over the trailing 6-month period	47.87%	43.66%	+4.21%
Volatility (1Y) Calculated over the trailing 1-year period	59.36%	62.97%	-3.61%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	69.19%	60.69%	+8.50%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	70.08%	64.38%	+5.70%

Dividends

RBLX vs. CRSP - Dividend Comparison

Neither RBLX nor CRSP has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both RBLX and CRSP in my portfolio?

RBLX and CRSP have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RBLX or CRSP?

CRSP has higher volatility (19.12%) compared to RBLX (17.33%). In terms of maximum drawdown, RBLX dropped -82.79% vs CRSP's -85.11%.

Which has better risk-adjusted returns?

CRSP currently has the higher Sharpe Ratio (0.55 vs -0.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.